TW205504B - - Google Patents

Download PDF

Info

Publication number: TW205504B
Authority: TW; Taiwan
Prior art keywords: patent application; item; glyceryl; composition according; composition
Prior art date: 1991-05-03

Application number

TW80108379A

Other languages

English (en)

Chinese (zh)

Original Assignee

Mcneil Ppc Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-03

Filing date

1991-10-24

Publication date

1993-05-11

1991-10-24 Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc

1993-05-11 Application granted granted Critical

1993-05-11 Publication of TW205504B publication Critical patent/TW205504B/zh

Links

ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 241
239000000203 mixture Substances 0.000 claims description 108
229940068939 glyceryl monolaurate Drugs 0.000 claims description 93
241000191967 Staphylococcus aureus Species 0.000 claims description 67
150000001875 compounds Chemical class 0.000 claims description 48
150000002148 esters Chemical class 0.000 claims description 42
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 41
238000004519 manufacturing process Methods 0.000 claims description 38
235000014113 dietary fatty acids Nutrition 0.000 claims description 31
239000000194 fatty acid Substances 0.000 claims description 31
229930195729 fatty acid Natural products 0.000 claims description 31
150000004665 fatty acids Chemical class 0.000 claims description 27
206010044248 Toxic shock syndrome Diseases 0.000 claims description 26
238000011049 filling Methods 0.000 claims description 26
206010040070 Septic Shock Diseases 0.000 claims description 25
231100000650 Toxic shock syndrome Toxicity 0.000 claims description 25
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 21
150000005690 diesters Chemical class 0.000 claims description 20
239000002253 acid Substances 0.000 claims description 18
235000011187 glycerol Nutrition 0.000 claims description 17
239000000052 vinegar Substances 0.000 claims description 17
235000021419 vinegar Nutrition 0.000 claims description 17
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 15
241000894006 Bacteria Species 0.000 claims description 13
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 12
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 11
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 10
108010006464 Hemolysin Proteins Proteins 0.000 claims description 10
229940074046 glyceryl laurate Drugs 0.000 claims description 10
239000003228 hemolysin Substances 0.000 claims description 10
239000007788 liquid Substances 0.000 claims description 8
OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 claims description 7
239000005639 Lauric acid Substances 0.000 claims description 7
241000194017 Streptococcus Species 0.000 claims description 7
231100000655 enterotoxin Toxicity 0.000 claims description 7
229940070765 laurate Drugs 0.000 claims description 7
GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 7
229940074049 glyceryl dilaurate Drugs 0.000 claims description 6
LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 claims description 6
POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims description 5
239000000147 enterotoxin Substances 0.000 claims description 5
229940075507 glyceryl monostearate Drugs 0.000 claims description 5
239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 5
235000017858 Laurus nobilis Nutrition 0.000 claims description 4
QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 claims description 4
235000005212 Terminalia tomentosa Nutrition 0.000 claims description 4
229940087068 glyceryl caprylate Drugs 0.000 claims description 4
101710146739 Enterotoxin Proteins 0.000 claims description 3
231100000776 exotoxin Toxicity 0.000 claims description 3
239000002095 exotoxin Substances 0.000 claims description 3
235000013372 meat Nutrition 0.000 claims description 3
229920005862 polyol Polymers 0.000 claims description 3
150000003077 polyols Chemical class 0.000 claims description 3
QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 claims description 2
229940080812 glyceryl caprate Drugs 0.000 claims 4
RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims 2
PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims 2
TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 2
TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims 1
235000021360 Myristic acid Nutrition 0.000 claims 1
244000125380 Terminalia tomentosa Species 0.000 claims 1
125000003158 alcohol group Chemical group 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
229940061567 glyceryl caprylate-caprate Drugs 0.000 claims 1
229940105132 myristate Drugs 0.000 claims 1
150000005846 sugar alcohols Polymers 0.000 claims 1
208000006379 syphilis Diseases 0.000 claims 1
230000002439 hemostatic effect Effects 0.000 description 139
101710101607 Toxic shock syndrome toxin-1 Proteins 0.000 description 100
238000012360 testing method Methods 0.000 description 69
210000004027 cell Anatomy 0.000 description 55
239000008280 blood Substances 0.000 description 46
210000004369 blood Anatomy 0.000 description 45
238000000034 method Methods 0.000 description 40
239000003053 toxin Substances 0.000 description 39
231100000765 toxin Toxicity 0.000 description 39
108700012359 toxins Proteins 0.000 description 39
230000000694 effects Effects 0.000 description 33
FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 32
230000012010 growth Effects 0.000 description 30
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
239000012530 fluid Substances 0.000 description 25
239000000047 product Substances 0.000 description 25
230000009467 reduction Effects 0.000 description 25
239000000243 solution Substances 0.000 description 23
238000002474 experimental method Methods 0.000 description 21
239000004615 ingredient Substances 0.000 description 18
241001465754 Metazoa Species 0.000 description 15
-1 plugs Substances 0.000 description 14
230000002829 reductive effect Effects 0.000 description 14
241000191940 Staphylococcus Species 0.000 description 13
230000015572 biosynthetic process Effects 0.000 description 12
230000002079 cooperative effect Effects 0.000 description 12
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 12
239000010931 gold Substances 0.000 description 12
229910052737 gold Inorganic materials 0.000 description 12
241000894007 species Species 0.000 description 12
238000011534 incubation Methods 0.000 description 11
230000002175 menstrual effect Effects 0.000 description 11
239000003921 oil Substances 0.000 description 11
239000000126 substance Substances 0.000 description 11
241000219095 Vitis Species 0.000 description 10
235000009754 Vitis X bourquina Nutrition 0.000 description 10
235000012333 Vitis X labruscana Nutrition 0.000 description 10
235000014787 Vitis vinifera Nutrition 0.000 description 10
239000002054 inoculum Substances 0.000 description 9
FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 9
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
239000000463 material Substances 0.000 description 8
239000000725 suspension Substances 0.000 description 8
210000001215 vagina Anatomy 0.000 description 8
229920000742 Cotton Polymers 0.000 description 7
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
230000033228 biological regulation Effects 0.000 description 7
239000004744 fabric Substances 0.000 description 7
239000003925 fat Substances 0.000 description 7
235000019197 fats Nutrition 0.000 description 7
238000002965 ELISA Methods 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
241000219094 Vitaceae Species 0.000 description 6
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
230000007423 decrease Effects 0.000 description 6
238000000502 dialysis Methods 0.000 description 6
235000021021 grapes Nutrition 0.000 description 6
238000011081 inoculation Methods 0.000 description 6
238000005259 measurement Methods 0.000 description 6
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 6
238000011160 research Methods 0.000 description 6
150000005691 triesters Chemical class 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
210000004556 brain Anatomy 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
230000023597 hemostasis Effects 0.000 description 5
230000002401 inhibitory effect Effects 0.000 description 5
LZMSXDHGHZKXJD-VJANTYMQSA-N trypanothione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H]1CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(=O)NCCCNCCCCNC(=O)CNC1=O LZMSXDHGHZKXJD-VJANTYMQSA-N 0.000 description 5
239000002699 waste material Substances 0.000 description 5
229920001817 Agar Polymers 0.000 description 4
101001023095 Anemonia sulcata Delta-actitoxin-Avd1a Proteins 0.000 description 4
101000641989 Araneus ventricosus Kunitz-type U1-aranetoxin-Av1a Proteins 0.000 description 4
101001028691 Carybdea rastonii Toxin CrTX-A Proteins 0.000 description 4
101000685083 Centruroides infamatus Beta-toxin Cii1 Proteins 0.000 description 4
101000685085 Centruroides noxius Toxin Cn1 Proteins 0.000 description 4
101001028688 Chironex fleckeri Toxin CfTX-1 Proteins 0.000 description 4
101000644407 Cyriopagopus schmidti U6-theraphotoxin-Hs1a Proteins 0.000 description 4
244000147568 Laurus nobilis Species 0.000 description 4
101000679608 Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) Cysteine rich necrotrophic effector Tox1 Proteins 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
206010041349 Somnolence Diseases 0.000 description 4
239000002250 absorbent Substances 0.000 description 4
230000002745 absorbent Effects 0.000 description 4
229940030225 antihemorrhagics Drugs 0.000 description 4
239000002775 capsule Substances 0.000 description 4
230000010261 cell growth Effects 0.000 description 4
239000003433 contraceptive agent Substances 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
235000013601 eggs Nutrition 0.000 description 4
235000013305 food Nutrition 0.000 description 4
230000000025 haemostatic effect Effects 0.000 description 4
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
238000009434 installation Methods 0.000 description 4
230000005906 menstruation Effects 0.000 description 4
238000012856 packing Methods 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 3
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
239000005711 Benzoic acid Substances 0.000 description 3
239000005642 Oleic acid Substances 0.000 description 3
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
241001415395 Spea Species 0.000 description 3
208000007536 Thrombosis Diseases 0.000 description 3
229960000583 acetic acid Drugs 0.000 description 3
239000008272 agar Substances 0.000 description 3
235000010419 agar Nutrition 0.000 description 3
235000010233 benzoic acid Nutrition 0.000 description 3
238000007906 compression Methods 0.000 description 3
230000006835 compression Effects 0.000 description 3
230000002254 contraceptive effect Effects 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
239000010696 ester oil Substances 0.000 description 3
239000000835 fiber Substances 0.000 description 3
239000006260 foam Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
238000001802 infusion Methods 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
229960002216 methylparaben Drugs 0.000 description 3
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
230000010412 perfusion Effects 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 3
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 3
229960003415 propylparaben Drugs 0.000 description 3
230000019100 sperm motility Effects 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
238000012546 transfer Methods 0.000 description 3
KEWIUFDNNIFKJK-KVVVOXFISA-N (z)-octadec-9-enoic acid;hydrate Chemical compound O.CCCCCCCC\C=C/CCCCCCCC(O)=O KEWIUFDNNIFKJK-KVVVOXFISA-N 0.000 description 2
ARXKVVRQIIOZGF-UHFFFAOYSA-N 1,2,4-butanetriol Chemical compound OCCC(O)CO ARXKVVRQIIOZGF-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
241001189861 Candidatus Goldbacteria Species 0.000 description 2
LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
241000995070 Nirvana Species 0.000 description 2
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
235000021314 Palmitic acid Nutrition 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
239000003929 acidic solution Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
239000000654 additive Substances 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000017531 blood circulation Effects 0.000 description 2
WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
ZDLBNXXKDMLZMF-UHFFFAOYSA-N cinitapride Chemical compound CCOC1=CC(N)=C([N+]([O-])=O)C=C1C(=O)NC1CCN(CC2CC=CCC2)CC1 ZDLBNXXKDMLZMF-UHFFFAOYSA-N 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
235000009508 confectionery Nutrition 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
239000008367 deionised water Substances 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
210000003298 dental enamel Anatomy 0.000 description 2
239000002781 deodorant agent Substances 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
235000013399 edible fruits Nutrition 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
230000035558 fertility Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
238000004898 kneading Methods 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
239000006187 pill Substances 0.000 description 2
230000001603 reducing effect Effects 0.000 description 2
102220034289 rs587777154 Human genes 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
150000004671 saturated fatty acids Chemical class 0.000 description 2
210000000582 semen Anatomy 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000001568 sexual effect Effects 0.000 description 2
230000035939 shock Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
230000001150 spermicidal effect Effects 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
230000000153 supplemental effect Effects 0.000 description 2
208000011580 syndromic disease Diseases 0.000 description 2
TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
150000004670 unsaturated fatty acids Chemical class 0.000 description 2
235000021122 unsaturated fatty acids Nutrition 0.000 description 2
DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
KUVAEMGNHJQSMH-UHFFFAOYSA-N (3-dodecanoyloxy-2-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCC KUVAEMGNHJQSMH-UHFFFAOYSA-N 0.000 description 1
NFCIIYARXMERLA-UHFFFAOYSA-N (4E)-4-[(3-methyl-1,3-benzothiazol-3-ium-2-yl)methylidene]-2-[(Z)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]-3-oxocyclobuten-1-olate Chemical compound S1C2=CC=CC=C2[N+](C)=C1C=C(C1=O)C([O-])=C1C=C1N(C)C2=CC=CC=C2S1 NFCIIYARXMERLA-UHFFFAOYSA-N 0.000 description 1
YZAZXIUFBCPZGB-QZOPMXJLSA-N (z)-octadec-9-enoic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O YZAZXIUFBCPZGB-QZOPMXJLSA-N 0.000 description 1
RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
PHDABSUWSFWIIF-UHFFFAOYSA-N 14,15-dihydroxypentadecanoic acid Chemical compound OCC(O)CCCCCCCCCCCCC(O)=O PHDABSUWSFWIIF-UHFFFAOYSA-N 0.000 description 1
239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
WGIMXKDCVCTHGW-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCO WGIMXKDCVCTHGW-UHFFFAOYSA-N 0.000 description 1
JPFNYQCURDHMDY-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCOCCO JPFNYQCURDHMDY-UHFFFAOYSA-N 0.000 description 1
OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
CTXGTHVAWRBISV-UHFFFAOYSA-N 2-hydroxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCO CTXGTHVAWRBISV-UHFFFAOYSA-N 0.000 description 1
BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
CVYRIYSTCBFCIE-UHFFFAOYSA-N 3-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCO CVYRIYSTCBFCIE-UHFFFAOYSA-N 0.000 description 1
RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
206010000234 Abortion spontaneous Diseases 0.000 description 1
241000222518 Agaricus Species 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
240000001592 Amaranthus caudatus Species 0.000 description 1
235000009328 Amaranthus caudatus Nutrition 0.000 description 1
235000018185 Betula X alpestris Nutrition 0.000 description 1
235000018212 Betula X uliginosa Nutrition 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
229920000298 Cellophane Polymers 0.000 description 1
229920002160 Celluloid Polymers 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
235000007516 Chrysanthemum Nutrition 0.000 description 1
244000189548 Chrysanthemum x morifolium Species 0.000 description 1
102100021899 Cyclin-L2 Human genes 0.000 description 1
RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
208000032928 Dyslipidaemia Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
241000272186 Falco columbarius Species 0.000 description 1
241000276423 Fundulus heteroclitus Species 0.000 description 1
229910052688 Gadolinium Inorganic materials 0.000 description 1
241000206672 Gelidium Species 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
206010018910 Haemolysis Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000897452 Homo sapiens Cyclin-L2 Proteins 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010062717 Increased upper airway secretion Diseases 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
208000017170 Lipid metabolism disease Diseases 0.000 description 1
101100518501 Mus musculus Spp1 gene Proteins 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
240000002853 Nelumbo nucifera Species 0.000 description 1
235000006508 Nelumbo nucifera Nutrition 0.000 description 1
235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
241000333181 Osmanthus Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
229920005830 Polyurethane Foam Polymers 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
241000205160 Pyrococcus Species 0.000 description 1
241000218206 Ranunculus Species 0.000 description 1
GNKFJROBICXUDN-UHFFFAOYSA-N S.IC Chemical compound S.IC GNKFJROBICXUDN-UHFFFAOYSA-N 0.000 description 1
241000239226 Scorpiones Species 0.000 description 1
241000033695 Sige Species 0.000 description 1
206010040844 Skin exfoliation Diseases 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
206010041925 Staphylococcal infections Diseases 0.000 description 1
101000794214 Staphylococcus aureus Toxic shock syndrome toxin-1 Proteins 0.000 description 1
ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
239000004376 Sucralose Substances 0.000 description 1
241000283068 Tapiridae Species 0.000 description 1
XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
108010021119 Trichosanthin Proteins 0.000 description 1
206010046914 Vaginal infection Diseases 0.000 description 1
244000126014 Valeriana officinalis Species 0.000 description 1
235000013832 Valeriana officinalis Nutrition 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
206010000496 acne Diseases 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
235000012735 amaranth Nutrition 0.000 description 1
239000004178 amaranth Substances 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229940069428 antacid Drugs 0.000 description 1
239000003159 antacid agent Substances 0.000 description 1
230000001458 anti-acid effect Effects 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
229960003237 betaine Drugs 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
238000007664 blowing Methods 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
229940114081 cinnamate Drugs 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
229940124558 contraceptive agent Drugs 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000010779 crude oil Substances 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
230000034994 death Effects 0.000 description 1
210000004268 dentin Anatomy 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000001784 detoxification Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
238000001035 drying Methods 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
235000003084 food emulsifier Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000002309 gasification Methods 0.000 description 1
235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
230000035784 germination Effects 0.000 description 1
229940074050 glyceryl myristate Drugs 0.000 description 1
208000024963 hair loss Diseases 0.000 description 1
230000003676 hair loss Effects 0.000 description 1
230000008588 hemolysis Effects 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
208000000509 infertility Diseases 0.000 description 1
230000036512 infertility Effects 0.000 description 1
231100000535 infertility Toxicity 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
238000010409 ironing Methods 0.000 description 1
239000013010 irrigating solution Substances 0.000 description 1
229910052743 krypton Inorganic materials 0.000 description 1
229910052746 lanthanum Inorganic materials 0.000 description 1
239000008141 laxative Substances 0.000 description 1
230000002475 laxative effect Effects 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
201000007227 lymph node tuberculosis Diseases 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
208000015994 miscarriage Diseases 0.000 description 1
238000002156 mixing Methods 0.000 description 1
NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
235000018342 monosodium citrate Nutrition 0.000 description 1
239000002524 monosodium citrate Substances 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229960002446 octanoic acid Drugs 0.000 description 1
SQABAALQCGKFFO-UHFFFAOYSA-N octanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC(O)=O SQABAALQCGKFFO-UHFFFAOYSA-N 0.000 description 1
235000019645 odor Nutrition 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
208000026435 phlegm Diseases 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
238000005375 photometry Methods 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
239000002574 poison Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920000166 polytrimethylene carbonate Polymers 0.000 description 1
239000011496 polyurethane foam Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
235000011151 potassium sulphates Nutrition 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
229960004134 propofol Drugs 0.000 description 1
239000008213 purified water Substances 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
229910052704 radon Inorganic materials 0.000 description 1
SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
206010037844 rash Diseases 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
235000021003 saturated fats Nutrition 0.000 description 1
235000003441 saturated fatty acids Nutrition 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000005245 sintering Methods 0.000 description 1
231100000046 skin rash Toxicity 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
229940001584 sodium metabisulfite Drugs 0.000 description 1
235000010262 sodium metabisulphite Nutrition 0.000 description 1
235000010344 sodium nitrate Nutrition 0.000 description 1
239000004317 sodium nitrate Substances 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
238000009987 spinning Methods 0.000 description 1
235000012461 sponges Nutrition 0.000 description 1
208000000995 spontaneous abortion Diseases 0.000 description 1
208000015339 staphylococcus aureus infection Diseases 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
229960001052 streptozocin Drugs 0.000 description 1
BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
235000019408 sucralose Nutrition 0.000 description 1
150000003871 sulfonates Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000004381 surface treatment Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000035488 systolic blood pressure Effects 0.000 description 1
239000012085 test solution Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
235000016788 valerian Nutrition 0.000 description 1
239000002435 venom Substances 0.000 description 1
231100000611 venom Toxicity 0.000 description 1
210000001048 venom Anatomy 0.000 description 1
230000001755 vocal effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
230000037303 wrinkles Effects 0.000 description 1
239000010930 yellow gold Substances 0.000 description 1
229910001097 yellow gold Inorganic materials 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1

Landscapes

Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TW80108379A 1991-05-03 1991-10-24 TW205504B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US69536691A	1991-05-03	1991-05-03

Publications (1)

Publication Number	Publication Date
TW205504B true TW205504B (de)	1993-05-11

Family

ID=51356720

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW80108379A TW205504B (de)	1991-05-03	1991-10-24

Country Status (1)

Country	Link
TW (1)	TW205504B (de)

1991
- 1991-10-24 TW TW80108379A patent/TW205504B/zh active

Publication	Publication Date	Title
JP3285600B2 (ja)	2002-05-27	女性用衛生製品に対する添加物
TW302279B (de)	1997-04-11
Pittet et al.	2005	Infection in breast implants
TWI716374B (zh)	2021-01-21	薄片紙及其製造方法、與吸收性物品
CN109381363A (zh)	2019-02-26	一种氨基酸洗发水及其制备方法
JP2018535933A (ja)	2018-12-06	パーソナルクレンジング組成物およびマイクロバイオームを安定化させる方法
CN106963697A (zh)	2017-07-21	一种具有控油、收缩毛孔功效的面膜液
CN105250189A (zh)	2016-01-20	一种祛痘修护精华霜及其制备方法
CN104042558A (zh)	2014-09-17	一种功能性女性护理湿巾及制备方法
PL97701B1 (pl)	1978-03-30	Srodek do hamowania procesu wytwarzania przez drobnoustroje niepozadanych kwasow tluszczowych przeznaczony do stosowania na tkanke skorna
JP2005516649A (ja)	2005-06-09	脂質中に懸濁された乳酸生成細菌を含む組成物で含浸された衛生ティッシュ
CN103990173A (zh)	2014-08-20	一种应用益生菌的功能性卫生巾及制备方法
CN111110577A (zh)	2020-05-08	一种温和型除螨止痒沐浴露及其制备方法
CN110420257A (zh)	2019-11-08	一种复合奶牛乳头药浴液及其制备方法
There et al.	2022	Formulation of hand made soap by using goat milk
CN110974717B (zh)	2021-08-06	一种可去污的滋润婴儿湿纸巾及其制备方法
CN107496235A (zh)	2017-12-22	一种婴幼儿口腔清洁湿巾及其制备方法
CN107007514A (zh)	2017-08-04	一种草本花水凝露及其制备方法
CN105997625A (zh)	2016-10-12	一种用于儿童皮肤粘膜日常保养的滋润乳及其应用
CN105012209A (zh)	2015-11-04	海洋鱼油沐浴露及其制备方法
CN115137685B (zh)	2024-04-05	一种温和清爽女性护理湿巾及其制备方法
JP2025531323A (ja)	2025-09-19	膣管用のスポンジ
CN108670893B (zh)	2019-05-28	氨基酸洁面乳组合物及其制备方法
CN118340831B (zh)	2026-01-06	一种可促进损伤表皮修复的奶牛乳头消毒液、制备方法及应用
US5489615A (en)	1996-02-06	Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof